Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Other Non-Current Assets (2024)

Updated

Analysis

Radiopharm Theranostics (RADX) Other Non-Current Assets (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 15.10 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 9.42 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - 700.00 Mn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 4.90 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 10.02 Bn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.00 Mn
API Access

Radiopharm Theranostics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RADX&period=max&api_key=YOUR_API_KEY